{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:24:05Z","timestamp":1786998245454,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.xphs.2020.09.050","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T22:02:52Z","timestamp":1602021772000},"page":"785-795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Glass Leachables as a Nucleation Factor for Free Fatty Acid Particle Formation in Biopharmaceutical Formulations"],"prefix":"10.1016","volume":"110","author":[{"given":"Andrea","family":"Allmendinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Lebouc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Bonati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Woehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravuri S.K.","family":"Kishore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Abstiens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.xphs.2020.09.050_bib1","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1002\/jps.21328","article-title":"Shaken, not stirred: mechanical stress testing of an IgG1 antibody","volume":"97","author":"Kiese","year":"2008","journal-title":"J\u00a0Pharm Sci"},{"issue":"Pt A","key":"10.1016\/j.xphs.2020.09.050_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejpb.2015.09.016","article-title":"Key interactions of surfactants in therapeutic protein formulations: a review","volume":"97","author":"Khan","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2020.09.050_bib3","series-title":"Challenges in Protein Product Development, AAPS Advances in the Pharmaceutical Sciences Series 38","first-page":"25","article-title":"Part II: challenges with excipients - polysorbate degradation and quality","author":"Kishore","year":"2018"},{"issue":"8","key":"10.1016\/j.xphs.2020.09.050_bib4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s11095-018-2430-5","article-title":"Considerations for the use of polysorbates in biopharmaceuticals","volume":"35","author":"Jones","year":"2018","journal-title":"Pharm Res"},{"issue":"8","key":"10.1016\/j.xphs.2020.09.050_bib5","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/jps.24054","article-title":"Ester hydrolysis of polysorbate 80 in mAb drug product: evidence in support of the hypothesized risk after the observation of visible particulate in mAb formulations","volume":"103","author":"Labrenz","year":"2014","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2020.09.050_bib6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.xphs.2019.10.015","article-title":"What makes polysorbate functional? Impact of polysorbate 80 grade and quality on IgG stability during mechanical stress","volume":"109","author":"Grabarek","year":"2020","journal-title":"J\u00a0Pharm Sci"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.09.050_bib7","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijpharm.2018.10.008","article-title":"Polysorbate degradation in biotherapeutic formulations: identification and discussion of current root causes","volume":"552","author":"Dwivedi","year":"2018","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2020.09.050_bib8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jps.24126","article-title":"Free fatty acid particles in protein formulations, part 1: microspectroscopic identification","volume":"104","author":"Cao","year":"2015","journal-title":"J\u00a0Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2020.09.050_bib9","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1007\/s11095-011-0385-x","article-title":"The degradation of polysorbates 20 and 80 and its potential impact on the stability of biotherapeutics","volume":"28","author":"Kishore","year":"2011","journal-title":"Pharm Res"},{"issue":"9","key":"10.1016\/j.xphs.2020.09.050_bib10","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1007\/s11095-015-1670-x","article-title":"Identification of subvisible particles in biopharmaceutical formulations using Raman spectroscopy provides insight into polysorbate 20 degradation pathway","volume":"32","author":"Saggu","year":"2015","journal-title":"Pharm Res"},{"issue":"11","key":"10.1016\/j.xphs.2020.09.050_bib11","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1021\/acs.molpharmaceut.5b00311","article-title":"Polysorbate 20 degradation in biopharmaceutical formulations: quantification of free fatty acids, characterization of particulates, and insights into the degradation mechanism","volume":"12","author":"Tomlinson","year":"2015","journal-title":"Mol Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2020.09.050_bib12","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1002\/jps.21190","article-title":"Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways","volume":"97","author":"Kerwin","year":"2008","journal-title":"J\u00a0Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2020.09.050_bib13","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.xphs.2016.02.022","article-title":"Polysorbates 20 and 80 degradation by Group XV lysosomal Phospholipase A2 isomer X1 in monoclonal antibody formulations","volume":"105","author":"Hall","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2020.09.050_bib14","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.xphs.2016.02.029","article-title":"Residual host cell protein promotes polysorbate 20 degradation in a sulfatase drug product leading to free fatty acid particles","volume":"105","author":"Dixit","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2020.09.050_bib15","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/bit.26237","article-title":"Knockout of a difficult-to-remove CHO host cell protein, lipoprotein lipase, for improved polysorbate stability in monoclonal antibody formulations","volume":"114","author":"Chiu","year":"2017","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"10.1016\/j.xphs.2020.09.050_bib16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1021\/bp050274w","article-title":"Exploitation of the adsorptive properties of depth filters for host cell protein removal during monoclonal antibody purification","volume":"22","author":"Yigzaw","year":"2006","journal-title":"Biotechnol Prog"},{"issue":"2","key":"10.1016\/j.xphs.2020.09.050_bib17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/19420862.2016.1267091","article-title":"Development of adsorptive hybrid filters to enable two-step purification of biologics","volume":"9","author":"Singh","year":"2017","journal-title":"MAbs"},{"issue":"1","key":"10.1016\/j.xphs.2020.09.050_bib18","doi-asserted-by":"crossref","first-page":"e1700771","DOI":"10.1002\/biot.201700771","article-title":"Improved HCP reduction using a new, all-synthetic depth filtration media within an antibody purification process","volume":"14","author":"Nguyen","year":"2019","journal-title":"Biotechnol J"},{"key":"10.1016\/j.xphs.2020.09.050_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.chroma.2019.02.056","article-title":"Identification and tracking of problematic host cell proteins removed by a synthetic, highly functionalized nonwoven media in downstream bioprocessing of monoclonal antibodies","volume":"1595","author":"Gilgunn","year":"2019","journal-title":"J\u00a0Chromatogr A"},{"issue":"10","key":"10.1016\/j.xphs.2020.09.050_bib20","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1021\/ac5009628","article-title":"Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry","volume":"86","author":"Li","year":"2014","journal-title":"Anal Chem"},{"issue":"11","key":"10.1016\/j.xphs.2020.09.050_bib21","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3109\/03639049809089948","article-title":"The composition of NF-defined emulsifiers: sorbitan monolaurate, monopalmitate, monostearate, monooleate, polysorbate 20, polysorbate 40, polysorbate 60, and polysorbate 80","volume":"24","author":"Brandner","year":"1998","journal-title":"Drug Dev Ind Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2020.09.050_bib22","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1021\/ac2005789","article-title":"Toward understanding molecular heterogeneity of polysorbates by application of liquid chromatography-mass spectrometry with computer-aided data analysis","volume":"83","author":"Borisov","year":"2011","journal-title":"Anal Chem"},{"issue":"15","key":"10.1016\/j.xphs.2020.09.050_bib23","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/j.chroma.2010.09.057","article-title":"Mixed-mode and reversed-phase liquid chromatography-tandem mass spectrometry methodologies to study composition and base hydrolysis of polysorbate 20 and 80","volume":"1218","author":"Hewitt","year":"2011","journal-title":"J\u00a0Chromatogr A"},{"issue":"6","key":"10.1016\/j.xphs.2020.09.050_bib24","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.xphs.2019.01.006","article-title":"Factors influencing polysorbate's sensitivity against enzymatic hydrolysis and oxidative degradation","volume":"108","author":"Kranz","year":"2019","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2020.09.050_bib25","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1208\/s12249-012-9759-6","article-title":"Effect of polysorbate 80 quality on photostability of a monoclonal antibody","volume":"13","author":"Singh","year":"2012","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.xphs.2020.09.050_bib26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/jps.24144","article-title":"Free fatty acid particles in protein formulations, part 2: contribution of polysorbate raw material","volume":"104","author":"Siska","year":"2015","journal-title":"J\u00a0Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2020.09.050_bib27","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1021\/acs.molpharmaceut.5b00310","article-title":"Understanding particle formation: solubility of free fatty acids as polysorbate 20 degradation byproducts in therapeutic monoclonal antibody formulations","volume":"12","author":"Doshi","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2020.09.050_bib28","series-title":"Complexity of the Analytical Characterization of Polysorbate - Case Studies for Degradation Profiling","author":"Wuchner","year":"2018"},{"issue":"12","key":"10.1016\/j.xphs.2020.09.050_bib29","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/nmat2301","article-title":"Insight into silicate-glass corrosion mechanisms","volume":"7","author":"Cailleteau","year":"2008","journal-title":"Nat Mater"},{"key":"10.1016\/j.xphs.2020.09.050_bib30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejpb.2017.12.018","article-title":"Characterization of surface properties of glass vials used as primary packaging material for parenterals","volume":"125","author":"Ditter","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10.1016\/j.xphs.2020.09.050_bib31","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.xphs.2017.09.016","article-title":"Evaluation of glass delamination risk in pharmaceutical 10 mL\/10R vials","volume":"107","author":"Ditter","year":"2018","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2020.09.050_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2019.03.030","article-title":"Monitoring polysorbate hydrolysis in biopharmaceuticals using a QC-ready free fatty acid quantification method","volume":"1116","author":"Honemann","year":"2019","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"7","key":"10.1016\/j.xphs.2020.09.050_bib33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11095-018-2421-6","article-title":"Impact of vial washing and depyrogenation on surface properties and delamination risk of glass vials","volume":"35","author":"Ditter","year":"2018","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2020.09.050_bib34","article-title":"Particulate contamination: visible particles [2.9.20]","volume":"4","year":"2020"},{"key":"10.1016\/j.xphs.2020.09.050_bib35","article-title":"Particulate contamination: subvisible particles [2.9.19]","volume":"4","year":"2020"},{"key":"10.1016\/j.xphs.2020.09.050_bib36","article-title":"Clarity and degree of opalescence of liquids [2.2.1]","volume":"4","year":"2020"},{"key":"10.1016\/j.xphs.2020.09.050_bib37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpba.2016.09.033","article-title":"Impact of mono- and poly-ester fractions on polysorbate quantitation using mixed-mode HPLC-CAD\/ELSD and the fluorescence micelle assay","volume":"132","author":"Lippold","year":"2017","journal-title":"J\u00a0Pharm Biomed Anal"},{"issue":"8","key":"10.1016\/j.xphs.2020.09.050_bib38","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1271\/bbb.66.1723","article-title":"Solubility of saturated fatty acids in water at elevated temperatures","volume":"66","author":"Khuwijitjaru","year":"2002","journal-title":"Biosci Biotechnol Biochem"},{"issue":"11","key":"10.1016\/j.xphs.2020.09.050_bib39","doi-asserted-by":"crossref","first-page":"6663","DOI":"10.1021\/acs.cgd.6b00794","article-title":"A\u00a0review of classical and nonclassical nucleation theories","volume":"16","author":"Karthika","year":"2016","journal-title":"Cryst Growth Des"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920305815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920305815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:31:49Z","timestamp":1758360709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354920305815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0022354920305815"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2020.09.050","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glass Leachables as a Nucleation Factor for Free Fatty Acid Particle Formation in Biopharmaceutical Formulations","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2020.09.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}